MSB 0.69% $1.46 mesoblast limited

Morningstar $2.10 valuation, page-11

  1. 4,695 Posts.
    lightbulb Created with Sketch. 720

    IF MPC-300-IV delivers, as hoped in its ongoing trials and cross fingers and toes, because thus far the data is very supportive, this application alone has MEGA-Blockbuster potential! I think all MSB is waiting for is to wrap-up the RA PhII, which, as I understand it, will happen this year and then expect to see this application march into PhIII pretty quickly [I reckon some govt coin might be headed out way too....who knows...it sure should], with MAYBE a breakthrough designation on the horizon as well.

    MPC-300-IV <<<<< hold on tight this baby's got the potential to jaw drop the entire field of medicine as we know it!

    "Look, your blood sugars are a little high.....go see the nurse down the hall, we'll address that today......NEXT.......ohhh look, you've got Osteoporosis....see the nurse.......NEXT........."

    Coming Soon to your local medical clinic! :cool: People happily pay for health resolutions......

    Go the Blaster!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.